Home » Diseases » Interfrontal Craniofaciosynostosis: Disease Bioinformatics
Submit your image related to Diseases to be featured!
Submit an Image

Get Social

Submit your Twitter account related to Interfrontal Craniofaciosynostosis to be featured!
Submit an Account

Blogs

 Submit your blog on Interfrontal Craniofaciosynostosis to be featured!
Submit a Blog

Events

 Submit your event on Interfrontal Craniofaciosynostosis to be featured!
Submit an Event

Videos

Submit your video on Interfrontal Craniofaciosynostosis to be featured!
Submit a Video

Charities

Submit your charity on Interfrontal Craniofaciosynostosis to be featured!
Submit a Charity

Interfrontal Craniofaciosynostosis: Disease Bioinformatics

Research of Interfrontal Craniofaciosynostosis has been linked to Craniosynostosis, Trigonocephaly, Congenital Abnormal Synostosis, Congenital Abnormality, Hemorrhage. The study of Interfrontal Craniofaciosynostosis has been mentioned in research publications which can be found using our bioinformatics tool below. Researched pathways related to Interfrontal Craniofaciosynostosis include Osteoblast Differentiation, Cell Growth, Wound Healing, Inflammatory Response. These pathways complement our catalog of research reagents for the study of Interfrontal Craniofaciosynostosis including antibodies and ELISA kits against GLI3, CER1, PTCH1, FREM1, BMP2.

Top Research Reagents

We have 2162 products for the study of Interfrontal Craniofaciosynostosis that can be applied to Chromatin Immunoprecipitation (ChIP), Flow Cytometry, Immunocytochemistry/ Immunofluorescence, Immunohistochemistry, Western Blot from our catalog of antibodies and ELISA kits.

Neurofibromin 1 Antibody
NB300-155
Western Blot: Neurofibromin 1 Antibody [NB300-155] - Western Blot of (A, B, C above).Immunohistochemistry: Neurofibromin 1 Antibody [NB300-155] - NF1 protein labeling displays positive signal in the maturing and the hypertrophic cartilages but only faint labeling in the proliferative cartilage.

Rabbit Polyclonal
Species Human, Mouse, Rat
Applications WB, ICC/IF, IHC

4 Publications
QBRICK/FREM1 Antibody - BSA Free
NBP1-77180
Western Blot: QBRICK/FREM1 Antibody [NBP1-77180] - K562 cell lysate with FREM1 antibody at (A) 0.5 and (B) 1ug/mL.Immunocytochemistry/Immunofluorescence: QBRICK/FREM1 Antibody [NBP1-77180] - K562 cells at 20 ug/mL.

Rabbit Polyclonal
Species Human, Mouse
Applications WB, ELISA, ICC/IF

Fibrillin 2 Antibody
NBP1-88169
Immunohistochemistry-Paraffin: Fibrillin 2 Antibody [NBP1-88169] - Staining in human placenta and prostate tissues using anti-FBN2 antibody. Corresponding FBN2 RNA-seq data are presented for the same tissues.Western Blot: Fibrillin 2 Antibody [NBP1-88169] - Analysis in human cell lines U2OS and A-431. Corresponding RNA-seq data are presented for the same cell lines. Loading control: Anti-PARP1.

Rabbit Polyclonal
Species Human
Applications WB, IHC, IHC-Fr

2 Publications
CDO Antibody [Unconjugated]
AF2429
Western blot shows lysate of C2C12 mouse myoblast cell line. PVDF membrane was probed with 0.25 µg/mL of Goat Anti-Mouse CDO Antigen Affinity-purified Polyclonal Antibody (Catalog # AF2429) followed by HRP-conjugated Anti-Goat IgG Secondary Antibody (Catalog # <a class=PKN2 levels are elevated during myoblast differentiation and decreased in Cdo-depleted cells with a concurrent reduction in AKT activation. (a) C2C12 cells were cultured to near confluency (D0) and induced to differentiate in differentiation medium (DM) for total 3 days (D3). Lysates were immunoblotted with antibodies to PKN2, Cdo, MHC, MyoD, myogenin, phosphorylated-AKT (p-AKT) and AKT. GAPDH and pan-Cadherin serve as loading controls. (b) Lysates of C2C12 cells transiently transfected with Cdo or control expression vectors as indicated were immunoblotted with antibodies to PKN2, Cdo, p-AKT and AKT. GAPDH and pan-Cadherin serve as loading controls. (c) Immunoblot analysis for the expression of PKN2, p-AKT and AKT proteins in Cdo+/+ and Cdo−/− primary myoblasts from hindlimb muscles, and pan-Cadherin serves as a loading control. (d) Photomicrographs of C2C12 cells that stably express PKN2 or control vectors were cultured in DM for 2 days, fixed, and immunostained with an antibody to MHC followed by DAPI staining to visualize nuclei. Size bar, 100 μm. (e) Quantification of myotube formation shown in (d). Values represent means of triplicate determinations ±1 S.D. The experiment was repeated three times with similar results. Significant difference from control, *P<0.01. (f) C2C12 cells stably transfected with shPKN2 or control (pSuper) vectors, and cultured to confluency and induced to differentiate for total 3 days. Cell lysates were immunoblotted using antibodies to PKN2, MHC, MyoD, Myogenin and pan-Cadherin as a loading control. (g) Photomicrographs of C2C12 cells stably transfected with PKN2 shRNA or control vectors were cultured in DM for 3 days, fixed and immunostained with an antibody to MHC followed by DAPI staining to visualize nuclei. Size bar, 100 μm. (h) Quantification of myotube formation by cell lines shown in (g). Values represent means of triplicate determinations ±1 S.D. The experiment was repeated three times with similar results. Significant difference from control, *P<0.01 Image collected and cropped by CiteAb from the following publication (https://www.nature.com/articles/cddis2016296), licensed under a CC-BY license. Not internally tested by R&D Systems.

Goat Polyclonal
Species Mouse
Applications WB, IHC

12 Publications
GLI-3 Antibody
AF3690
Western blot shows lysates of mouse embryo tissue. PVDF membrane was probed with 1 µg/mL of Goat Anti-Human/Mouse GLI-3 Antigen Affinity-purified Polyclonal Antibody (Catalog # AF3690) followed by HRP-conjugated Anti-Goat IgG Secondary Antibody (Catalog # <a class=Jurkat human acute T cell leukemia cell line treated with 50 ng/mL PMA and 200 ng/mL calcium ionomycin for 30 minutes was fixed using formaldehyde, resuspended in lysis buffer, and sonicated to shear chromatin. GLI‑3/DNA complexes were immunoprecipitated using 5 μg Goat Anti-Human/Mouse GLI‑3 Antigen Affinity-purified Polyclonal Antibody (Catalog # AF3690) or control antibody (Catalog # <A class=NoLineLink href=

Goat Polyclonal
Species Human, Mouse
Applications WB, ChIP, ICC

     3 Reviews

100 Publications
TINAGL1 Antibody (812417)
MAB7185
Western blot shows lysates of human placenta tissue and human kidney tissue. PVDF membrane was probed with 0.5 µg/mL of Mouse Anti-Human TINAGL1 Monoclonal Antibody (Catalog # MAB7185) followed by HRP-conjugated Anti-Mouse IgG Secondary Antibody (Catalog # <a class=Simple Western lane view shows lysates of human placenta tissue, loaded at 0.5 mg/mL. A specific band was detected for TINAGL1 at approximately 59 kDa (as indicated) using 5 µg/mL of Mouse Anti-Human TINAGL1 Monoclonal Antibody (Catalog # MAB7185). This experiment was conducted under reducing conditions and using the 12-230 kDa separation system. </P><P>Non-specific interaction with the 230 kDa Simple Western standard may be seen with this antibody.

Mouse Monoclonal
Species Human
Applications WB, Simple Western

RFC1 Antibody [Unconjugated]
AF6457
Western blot shows lysates of Daudi human Burkitt's lymphoma cell line. Gels were loaded with 30 µg of whole cell lysate (WCL), 20 µg of cytoplasmic (Cyto), and 10 µg of nuclear extracts (Nuc). PVDF Membrane was probed with 1 µg/mL of Sheep Anti-Human RFC1 Antigen Affinity-purified Polyclonal Antibody (Catalog # AF6457) followed by HRP-conjugated Anti-Sheep IgG Secondary Antibody (Catalog # <a class=

Sheep Polyclonal
Species Human
Applications WB

RUNX2/CBFA1 Antibody (232902) [Unconjugated]
MAB2006
RUNX2/CBFA1 was detected in immersion fixed U2OS human osteosarcoma cell line using Rat Anti-Human RUNX2/CBFA1 Monoclonal Antibody (Catalog # MAB2006) at 10 µg/mL for 3 hours at room temperature. Cells were stained using the NorthernLights™ 557-conjugated Anti-Rat IgG Secondary Antibody (red, upper panel; Catalog # <a class=

Rat Monoclonal
Species Human
Applications ICC

     1 Review

28 Publications
Patched 1/PTCH Antibody (413220) [Unconjugated] - (First Extracellular Loop)
MAB41051
Western blot shows lysates of MEF mouse embryonic feeder cells, Neuro-2A mouse neuroblastoma cell line, and mouse brain tissue. PVDF Membrane was probed with 1 µg/mL of Rat Anti-Human/Mouse Patched 1/PTCH (First Extracellular Loop) Monoclonal Antibody (Catalog # MAB41051) followed by HRP-conjugated Anti-Rat IgG Secondary Antibody (Catalog # <a class=Patched was detected in immersion fixed frozen sections of mouse spinal cord using 10 µg/mL Rat Anti-Human/Mouse Patched 1/PTCH (First Extracellular Loop) Monoclonal Antibody (Catalog # MAB41051) overnight at 4 °C. Tissue was stained (red) and counterstained with DAPI (blue). View our protocol for <A class=NoLineLink href=

Rat Monoclonal
Species Human, Mouse
Applications WB, IHC

10 Publications
Cerberus 1 Antibody (225807)
MAB1986

Rat Monoclonal
Species Mouse
Applications WB

11 Publications
Twist-1 Antibody (10E4E6) - BSA Free
NBP2-37364
Western Blot: Twist-1 Antibody (10E4E6) [NBP2-37364] - Analysis using TWIST1 mouse mAb against NIH/3T3 (1), JURKAT (2), HELA (3), A549 (4), RAJI (5) and OCM-1 (6) cell lysate.Immunocytochemistry/Immunofluorescence: Twist-1 Antibody (10E4E6) [NBP2-37364] - Analysis of HeLa cells using TWIST1 mouse mAb (green). Blue: DRAQ5 fluorescent DNA dye.

Mouse Monoclonal
Species Human, Mouse
Applications WB, ELISA, Flow

     1 Review

9 Publications
Fucosyltransferase 2/FUT2
7770-GT


Species Human
Applications EnzAct

2 Publications
BMP-2 [Unconjugated]
355-BM
Recombinant human/mouse/rat BMP-2 (<a class=NoLineLink href=


Species Human, Mouse, Rat
Applications BA

187 Publications
p14ARF/CDKN2A Antibody - BSA Free
NB200-111
Knockdown Validated: p14ARF/CDKN2A Antibody [NB200-111] - Inhibition of AKT decreases p53mut stability. T24 cells were transfected with non-targeting control, AKT1, or p14ARF siRNA. Cells were treated with NCS348884 (4 i1/4M), Nutlin3A (5 i1/4M) or DMSO as indicated. Whole cell lysates were probed with the indicated antibodies. Image collected and cropped by Citeab from the following publication (AKT regulates NPM dependent ARF localization and p53mut stability in tumors. <i>Oncotarget</i> (2014)) licensed under a CC-BY license.Immunohistochemistry: p14ARF/CDKN2A Antibody [NB200-111] - Inhibition of AKT modulates p53 stability in-vivo and synergizes with ionizing radiation to inhibit tumor growth( Sections of PSN1 xenografts treated with three consecutive doses of MK-2206 (60 mg/kg). Sections of PSN1 xenografts and in-vitro PSN1 cells fixed and stained with anti-NPM (red) and anti-p14ARF (green). Image collected and cropped by Citeab from the following publication (AKT regulates NPM dependent ARF localization and p53mut stability in tumors. Oncotarget (2014)) licensed under a CC-BY license.

Rabbit Polyclonal
Species Human, Mouse
Applications WB, Flow, ICC/IF

     2 Reviews

17 Publications
RFC2 Antibody (OTI2B2) - Azide and BSA Free
NBP2-73857
Western Blot: RFC2 Antibody (OTI2B2) - Azide and BSA Free [NBP2-73857] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY RFC2.Immunohistochemistry: RFC2 Antibody (OTI2B2) - Azide and BSA Free [NBP2-73857] - Analysis of Human prostate tissue.

Mouse Monoclonal
Species Human, Mouse, Rat
Applications WB, Flow, IHC

Myoglobin Antibody (2269B) [Unconjugated]
MAB97203
Western blot shows lysates of human heart tissue, mouse heart tissue, rat heart tissue, and human liver tissue. PVDF membrane was probed with 0.5 µg/mL of Rabbit Anti-Human Myoglobin Monoclonal Antibody (Catalog # MAB97203) followed by HRP-conjugated Anti-Rabbit IgG Secondary Antibody (Catalog # <a class= Myoglobin was detected in immersion fixed paraffin-embedded sections of human heart using Rabbit Anti-Human Myoglobin Monoclonal Antibody (Catalog # MAB97203) at 3 µg/mL for 1 hour at room temperature followed by incubation with the Anti-Rabbit IgG VisUCyte™ HRP Polymer Antibody (Catalog # <a class=

Rabbit Monoclonal
Species Human, Mouse, Rat
Applications WB, Simple Western, ELISA

FGFR1 Antibody (M19B2) - BSA Free
NB600-1287
Western Blot: FGF R1 Antibody (M19B2) [NB600-1287] - Analysis of MCF7 (A), HepG2 (B), NIH3T3 (C), and PC-12 (D) cell lysate using FGF R1 antibody at 2 ug/ml.Flow Cytometry: FGF R1 Antibody (M19B2) [NB600-1287] - Analysis using the Alexa Fluor 488 (R) conjugate of NB600-1287. Staining of FGF R1 in HEK293 and HEK293 FGFR transfected cells using anti-FGF R1 antibody. (Red) Positive cells, (Green) Negative cells, (Blue) Negative cells + antibody, (Pink) Positive cells + antibody. Image from verified customer review.

Mouse Monoclonal
Species Human, Mouse, Rat
Applications WB, Flow, ICC/IF

     1 Review

7 Publications
FGFR2 Antibody (1G3)
H00002263-M01
Western Blot: FGFR2 Antibody (1G3) [H00002263-M01] - Analysis of FGFR2 expression in transfected 293T cell line by FGFR2 monoclonal antibody (M01), clone 1G3.Lane 1: FGFR2 transfected lysate (Predicted MW: 92 KDa).Lane 2: Non-transfected lysate.Immunohistochemistry-Paraffin: FGFR2 Antibody (1G3) [H00002263-M01] - Analysis of monoclonal antibody to FGFR2 on formalin-fixed paraffin-embedded human stomach carcinoma tissue. Antibody concentration 5 ug/ml.

Mouse Monoclonal
Species Human, Bovine
Applications WB, ELISA, ICC/IF

13 Publications

Related Genes

Interfrontal Craniofaciosynostosis has been researched against:

Related Pathways

Interfrontal Craniofaciosynostosis has been linked to:

Related Diseases

Interfrontal Craniofaciosynostosis has been studied in relation to diseases such as:

Alternate Names

Interfrontal Craniofaciosynostosis is also known as Metopic Craniosynostosis.